In order to operate the site and better serve you, we collect your data. We also use this data and share with our vendors for the purposes of marketing, research, and monitoring.
Overview Jakafi is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera… read more
Join